| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |